Aquestive Therapeutics, Inc. AQST Business Segments — Other income/(expenses), net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net?
- Aquestive Therapeutics, Inc. (AQST) reported business segments — other income/(expenses), net of -$3.85M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net changed year-over-year?
- Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net decreased by 8.1% year-over-year, from -$3.57M to -$3.85M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net has grown at a 30.5% compound annual growth rate (CAGR), from $7.48M to -$12.73M.
- What does business segments — other income/(expenses), net mean?
- Captures non-operating financial items such as interest income, interest expense, foreign exchange gains or losses, and other miscellaneous financial activities. This metric reflects the impact of the segment's capital structure and external financial factors on its bottom line. It is essential for distinguishing between core operational performance and peripheral financial results.